Impaired interleukin-12-dependent T-cell functions during aging: Role of signal transducer and activator of transcription 4 (STAT4) and suppressor of cytokine signaling 3 (SOCS3)

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 2, 2006, Pages 125-135

  Tortorella, Cosimo ^a,b   Stella, Isabella ^a   Piazzolla, Giuseppina ^a   Cappiello, Valentina ^a   Simone, Olivia ^a   Pisconti, Addolorata ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHYTOHEMAGGLUTININ; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; AGED; AGING; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TH1 CELL;

EID: 33644689250     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.2.125     Document Type: Article

References (43)

1. Nagel JE, Chopra RK, Chrest FJ, et al. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohaemagglutinin-stimulated cells from elderly donors. J Clin Invest. 1988;81:1096-1102.
2. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
3. + CTL activity among elderly persons and the enhancing effect of IL-12. Mech Age Dev. 1997;94:25-39.
4. + T cell subsets. Arch Gerontol Geriatr. 1997;26:55-70.
5. - T cells in the aging immune system. Mech Age Dev. 1998;102:131-147.
6. Shearer GM. Th1/Th2 changes in aging. Mech Age Dev. 1997;94:1-5.
7. Hobbs MV, Weigle WO, Noonan DJ, et al. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol. 1993;150:3602-3614.
8. Cakman I, Rohwer J, Shütz RM, Kirchner H, Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Age Dev. 1996;87:197-209.
9. Lio D, Balistreri CR, Candore G, et al. In vitro treatment with interleukin-2 normalizes type-1 cytokine production by lymphocytes from elderly. Immunopharmacol Immunotoxicol. 2000;22:195-203.
10. Quyang Q, Cicek G, Westendorp RGJ, Cools HJM, Van der Klis RJ, Remarque EJ. Reduced IFNγ production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech Age Dev. 2000;121:131-137.
11. + T cells differentiation in vivo. Clin Exp Immunol. 1994;96:528-534.
12. Paganelli R, Scala E, Rosso R, et al. A shift to THO cytokine production by CD4+cells in human longevity: studies on two healthy centenarians. Eur J Immunol. 1996;26:2030-2034.
13. Gardner EM, Murasko DM. Age-related changes in Type 1 and Type 2 cytokine production in humans. Bio gerontology. 2002;3:271-289.
14. Rafi A, Castle SC, Uyemura K, Makinodan T. Immune dysfunction in the elderly and its reversal by antihistamines. Biomed Pharmacother. 2003;57:246-250.
15. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol. 2004;172:3437-3446.
16. Burton JD, Bamford RN, Peters C, et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994;91:4935-4939.
17. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptative immunity. Annu Rev Immunol. 1995;13:251-276.
18. Tortorella C, Pisconti A, Piazzolla G, Antonaci S. APC-dependent impairment of T cell proliferation in aging: role of CD28- and IL-12/IL-15-mediated signaling. Mech Age Dev. 2002;123:1389-1402.
19. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Age Dev. 1990;28:47-55.
20. + memory T cells with different capacities to induce B cell differentiation. J. Immunol. 1995;155:149-162.
21. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174-177.
22. Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 2000;382:171-174.
23. Zhang S, Kaplan MH. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J Immunol. 2000;165:1374-1380.
24. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 2000;18:143-164.
25. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2002;2:410-416.
26. Yamamoto K, Yamaguchi M, Miyasaka N, Miura O. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor 2 subunit. Biochem Biophys Res Commun. 2003;310:1188-1193.
27. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 2004;202:139-156.
28. Bernstein ED, Murasko DM. Effect of age on cytokine production in humans. Age. 1998;21:137-151.
29. + T cells in the absence of TCR ligation. J Immunol. 1998;161:3408-3415.
30. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol. 1998;161:3400-3407.
31. Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med. 1994;180:211-222.
32. Gangemi S, Basile G, Merendino RA, et al. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity? Exp Gerontol. 2003;38:669-672.
33. - T cells in healthy ageing people, including centenarians. Immunology. 1996;88:501-507.
34. Presky DH, Yang H, Minetti LJ, et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A. 1996;93:14002-14007.
35. Zou J, Presky DH, Wu CY, Gubler U. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and 2 and JAK kinases. J Biol Chem. 1997;272:6073-6077.
36. Lawless VA, Zhang S, Ozes ON, et al. Stat4 regulates multiple components of IFN-γ-inducing signaling pathways. J Immunol. 2000;165:6803-6808.
37. Parrello T, Monteleone G, Cucchiara S, et al. Up-regulation of the IL-12 receptor β2 chain in Crohn's disease. J Immunol. 2000;165:7234-7239.
38. Naeger LK, McKinney J, Salvekar A, Hoey T. Identification of a Stat4 binding site in the interleukin-12 receptor required for signaling. J Biol Chem. 1999;274:1875-1878.
39. Xu X, Sun YL, Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science. 1996;273:794-797.
40. Yu CR, Mahdi RM, Ebong S, Vistica BP, Gery I, Egwuagu CE. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J Biol Chem. 2003;278:29752-29759.
41. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol. 2002;168:3181-3187.
42. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Age Dev. 1998;102:199-209.
43. Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans. 2003;31:457-461.